Human lymphoblastoid cells as a source of interferon

Area of Science:

• Biotechnology
• Immunology
• Oncology

Background:

• Interferons possess significant antitumor effects observed in animal studies and clinical trials for osteosarcomas and other cancers.
• Current production of human interferons primarily relies on human white blood cells (buffy coats), yielding limited quantities.
• Alternative sources like human fibroblast cell lines produce interferons with different properties compared to leukocyte interferon.

Purpose of the Study:

• To explore the potential of lymphoblastoid cells as a source for interferon production.
• To compare the interferon produced by lymphoblastoid cells with that derived from buffy coats.
• To discuss the advantages and challenges of using lymphoblastoid cell suspension cultures for large-scale interferon manufacturing.

Main Methods:

• Induction of interferon production in human lymphoblastoid cell lines.
• Cultivation of lymphoblastoid cells in suspension culture systems.
• Characterization of the biological and chemical properties of the produced interferon.

Main Results:

• Lymphoblastoid cells can be induced to produce interferon.
• The interferon generated from lymphoblastoid cells is biochemically and biologically identical to buffy coat interferon.
• Lymphoblastoid cells can be cultured in large suspension tanks, enabling mass production.

Conclusions:

• Lymphoblastoid cell lines represent a viable and scalable source for producing high-quality interferon.
• This production method offers a potentially more cost-effective and abundant supply of interferon for therapeutic use.
• Further investigation into the advantages and challenges of this production system is warranted for clinical application.